Safety and Efficacy Data: The CheckMate 214 Trial

Mehmet Asim Bilen, MD, summarizes data from the CheckMate 214 trial on the safety and efficacy of ipilimumab/nivolumab versus sunitinib.

Related Videos
Experts on multiple myeloma
Experts on multiple myeloma
Experts on breast cancer
Experts on breast cancer
Experts on multiple myeloma
Experts on multiple myeloma
Experts on breast cancer
Hope S. Rugo, MD, an expert on breast cancer
Experts on breast cancer
Experts on breast cancer
Related Content